These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 17665896)

  • 1. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
    Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
    J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates.
    Venkatesan AM; Gu Y; Dos Santos O; Abe T; Agarwal A; Yang Y; Petersen PJ; Weiss WJ; Mansour TS; Nukaga M; Hujer AM; Bonomo RA; Knox JR
    J Med Chem; 2004 Dec; 47(26):6556-68. PubMed ID: 15588091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum beta-lactamase inhibitors: evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods.
    Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Ado M; Tsuyoshi T; Dos Santos O; Gu Y; Sum FW; Li Z; Francisco G; Lin YI; Petersen PJ; Yang Y; Kumagai T; Weiss WJ; Shlaes DM; Knox JR; Mansour TS
    J Med Chem; 2006 Jul; 49(15):4623-37. PubMed ID: 16854068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5,5,6-Fused tricycles bearing imidazole and pyrazole 6-methylidene penems as broad-spectrum inhibitors of beta-lactamases.
    Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Ado M; Tsuyoshi T; Dos Santos O; Li Z; Francisco G; Lin YI; Petersen PJ; Yang Y; Weiss WJ; Shlaes DM; Mansour TS
    Bioorg Med Chem; 2008 Feb; 16(4):1890-902. PubMed ID: 18061461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-ketophosphonates as beta-lactamase inhibitors: Intramolecular cooperativity between the hydrophobic subsites of a class D beta-lactamase.
    Perumal SK; Adediran SA; Pratt RF
    Bioorg Med Chem; 2008 Jul; 16(14):6987-94. PubMed ID: 18572409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate.
    Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR
    Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered Amp C β-lactamase as a fluorescent screening tool for class C β-lactamase inhibitors.
    Tsang MW; Chan PH; So PK; Ma DL; Tsang CW; Wong KY; Leung YC
    Anal Chem; 2011 Mar; 83(6):1996-2004. PubMed ID: 21338058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of BRL 42715, C6-(N1-methyl-1,2,3-triazolylmethylene)penem, in complex with Enterobacter cloacae 908R beta-lactamase: evidence for a stereoselective mechanism from docking studies.
    Michaux C; Charlier P; Frère JM; Wouters J
    J Am Chem Soc; 2005 Mar; 127(10):3262-3. PubMed ID: 15755127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and structural consequences of the leaving group in substrates of a class C beta-lactamase.
    Ahn YM; Pratt RF
    Bioorg Med Chem; 2004 Mar; 12(6):1537-42. PubMed ID: 15018927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors.
    Silvaggi NR; Kaur K; Adediran SA; Pratt RF; Kelly JA
    Biochemistry; 2004 Jun; 43(22):7046-53. PubMed ID: 15170342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams.
    Heinze-Krauss I; Angehrn P; Charnas RL; Gubernator K; Gutknecht EM; Hubschwerlen C; Kania M; Oefner C; Page MG; Sogabe S; Specklin JL; Winkler F
    J Med Chem; 1998 Oct; 41(21):3961-71. PubMed ID: 9767633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spirocyclopropyl beta-lactams as mechanism-based inhibitors of serine beta-lactamases. Synthesis by rhodium-catalyzed cyclopropanation of 6-diazopenicillanate sulfone.
    Sandanayaka VP; Prashad AS; Yang Y; Williamson RT; Lin YI; Mansour TS
    J Med Chem; 2003 Jun; 46(13):2569-71. PubMed ID: 12801220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase.
    Kim JY; Jung HI; An YJ; Lee JH; Kim SJ; Jeong SH; Lee KJ; Suh PG; Lee HS; Lee SH; Cha SS
    Mol Microbiol; 2006 May; 60(4):907-16. PubMed ID: 16677302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
    Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
    Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of antibiotic resistance: QM/MM modeling of the acylation reaction of a class A beta-lactamase with benzylpenicillin.
    Hermann JC; Hensen C; Ridder L; Mulholland AJ; Höltje HD
    J Am Chem Soc; 2005 Mar; 127(12):4454-65. PubMed ID: 15783228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.
    Xia Y; Cao K; Zhou Y; Alley MR; Rock F; Mohan M; Meewan M; Baker SJ; Lux S; Ding CZ; Jia G; Kully M; Plattner JJ
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2533-6. PubMed ID: 21392987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomolar inhibitors of AmpC beta-lactamase.
    Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
    J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the importance of a methyl group in beta-lactamase evolution: free energy profiles and molecular modeling.
    Bernstein NJ; Pratt RF
    Biochemistry; 1999 Aug; 38(32):10499-510. PubMed ID: 10441146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel imidazole substituted 6-methylidene-penems as broad-spectrum beta-lactamase inhibitors.
    Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Kumagai T; Petersen PJ; Weiss WJ; Lenoy E; Yang Y; Shlaes DM; Ryan JL; Mansour TS
    Bioorg Med Chem; 2004 Nov; 12(22):5807-17. PubMed ID: 15498657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.